ELTROMBOPAG OLAMINE
Generic: ELTROMBOPAG OLAMINE
Somerset TherapeuticsManufacturer
ORALRoute
ELTROMBOPAG OLAMINEActive Substance
2026-01-14Original Approval
ELTROMBOPAG OLAMINE is FDA application ANDA219638, sponsored by SOMERSET THERAPS LLC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
PLATELET COUNT DECREASED
1,692 reports
2
DRUG INEFFECTIVE
872 reports
3
OFF LABEL USE
735 reports
4
DEATH
595 reports
5
PRODUCT USE IN UNAPPROVED INDICATION
442 reports
6
PLATELET COUNT INCREASED
408 reports
7
THROMBOCYTOPENIA
399 reports
8
HEADACHE
384 reports
9
FATIGUE
360 reports
10
HAEMOGLOBIN DECREASED
336 reports